Perspective from the heartland: Cancer care and research during a public health crisisMarch 26, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
Cancer care and COVID-19 in Seattle, the first U.S. epicenterMarch 23, 2020COVID-19 UpdatesCNS/Brain CancerBreast CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
How is oncology adapting to COVID-19?March 23, 2020COVID-19 UpdatesBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Disruptions in cancer care in the era of COVID-19March 20, 2020COVID-19 UpdatesPatient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic Cancer
Study supports genetic testing for all breast cancer patients age 65 and youngerMarch 16, 2020Breast Cancer
Largest meeting on cancer research canceled: AACRMarch 11, 2020Mixed TopicsLung CancerHead & Neck/Thyroid CancersGynecologic CancerGenitourinary CancerGastroenterologyCNS/Brain Cancer
HRQOL deteriorates after disease progression in metastatic cancerMarch 11, 2020Patient & Survivor CareLung CancerGastroenterologyBreast CancerGenitourinary CancerMixed TopicsMetastatic Breast Cancer
Abbreviated MRI bests digital breast tomosynthesis in finding cancer in dense breastsFebruary 27, 2020Breast Cancer
FDA approves neratinib in combination for metastatic HER2-positive breast cancerFebruary 27, 2020Breast CancerFDA ActionsMetastatic Breast Cancer
